Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...

The California Institute for Regenerative Medicine and its partners are selling thousands of stem cell samples before many of ...

As a marker of minimal residual disease in B-cell acute lymphoblastic leukemia (B-ALL), CD58 has been reported in B-ALL at diagnosis and short-term follow-ups after standard chemotherapies. However, ...

Carfilzomib is under development for the treatment of newly diagnosed primary plasma cell leukemia, kidney, amyloidosis, hematological malignancies including lymphoma, T-Cell lymphomas, relapsed or ...

Induction treatment for childhood acute lymphoblastic leukaemia (ALL) The aim of induction is to get rid of as many leukaemia cells as possible. It's also called remission induction. In remission ...

Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data demonstrating that adding ...

Approval of Aucatzyl was based on results of the FELIX trial, which demonstrated a 63% overall complete remission rate among efficacy-evaluable patients with relapsed/refractory B-cell acute ...

A blast cell is an immature cell in the bone marrow that gives rise to mature lines of blood cells, In the case of lymphoblastic lymphoma, the disordered cell is a lymphoblast that would normally ...

A myeloid stem cell can then develop into several other types of cells, including myeloblasts, while a lymphoid stem cell matures into a lymphoblast. Myeloblasts then mature into white blood cells ...

Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without ...